Liberation of galactose from lactose by gut microbial β-galactosidase prevents uterine bacterial infection
The ISME Journal · 2025
DOI: 10.1093/ismejo/wraf185 ↗Kurz gefasst
Fachartikel in der Zeitschrift The ISME Journal, 2025. Verfasst von Jiapei Cai und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Educ…. Hauptthemen laut MEDLINE: Lactose, beta-Galactosidase, Galactose, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Reproductive infection is closely associated with adverse reproductive outcomes, contributing to a reduced live birth rate per pregnancy and an elevated infertility rate. Nutrition is widely acknowledged as a fundamental determinant of human and animal health, as well as the etiopathogenesis of various diseases, with the gut microbiota playing an integral part in this process. Lactose, a disaccharide present in mammalian milk, has been identified as a potential prebiotic. Here, we found that lactose was able to mitigate the inflammatory response elicited by uterine bacterial infection, preserve the integrity of the endometrial epithelial barrier, and reduce the bacterial load in the uterus. The protective effects of lactose were found to be gut microbiota-dependent and fecal microbiota transplantation from lactose-treated mice to recipient mice also ameliorated E. coli-induced metritis. 16S rRNA gene amplicon sequencing revealed that lactose supplementation changed the gut microbiota, specifically increasing the abundance of Lactobacillus intestinalis (L. intestinalis). Whole-genome sequencing identified that L. intestinalis expressed β-galactosidase, a lactose-metabolizing enzyme. Inhibition or exogenous supplementation of β-galactosidase confirmed its essential role in mediating lactose’s protective effects against E. coli uterine infection. Furthermore, intragastric administration of [1-13Cgal]-lactose confirmed that galactose, a lactose metabolite, could translocate from the gut to the uterus. Mechanistically, galactose upregulated the CEBPB-dependent S100a8 expression after E. coli infection, and the protective effect could be blunted by S100a8 inhibition. Collectively, these findings highlight a nutrition-microbiota-host interaction that is stimulated by lactose supplementation, providing potential benefits for reproductive infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jili…
ORCID-Profile: Yongguo Cao
Zitieren
APA
Cai, J., Zhang, X., He, Y., Qu, L., Liu, J., Xie, X., & Cao, Y. (2025). Liberation of galactose from lactose by gut microbial β-galactosidase prevents uterine bacterial infection. The ISME Journal. https://doi.org/10.1093/ismejo/wraf185
Vancouver
Cai J, Zhang X, He Y, Qu L, Liu J, Xie X, et al. Liberation of galactose from lactose by gut microbial β-galactosidase prevents uterine bacterial infection. The ISME Journal. 2025. doi:10.1093/ismejo/wraf185
BibTeX
@article{Cai2025,
author = {Cai, Jiapei and Zhang, Xinyu and He, Yuhang and Qu, Linkai and Liu, Jiuxi and Xie, Xufeng and Cao, Yongguo},
title = {Liberation of galactose from lactose by gut microbial β-galactosidase prevents uterine bacterial infection},
journal = {The ISME Journal},
year = {2025},
doi = {10.1093/ismejo/wraf185}
}
EUVIMED